Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02890810 · ClinicalTrials.gov registry record · NA
Predicting Analgesic Response to Acupuncture: A Practical Approach
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT02890810: Completed NA study, sponsored by Stanford University.
NCT02890810 is a NA study that has completed, run by Stanford University. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02890810, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
In this placebo controlled, patient and assessor blinded clinical trial, the investigators will administer electroacupuncture vs sham electroacupuncture to patients suffering from chronic low back pain, and monitor their symptoms as well as collecting objective outcome measures. The investigators objective is to identify predictors of pain reduction and functional improvement with electroacupuncture vs placebo.
Primary Outcome
Patient self-reported mean back pain intensity on 11 point (0-10) numerical rating scale (NRS).
Interventions
- OTHER Real Acupuncture with Electrical Stimulation
- OTHER Simulated Acupuncture with Electrical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT02890810 record still lists
NCT02890810 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Real Acupuncture with Electrical Stimulation is the first listed.
NCT02890810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02890810 about?
NCT02890810 is a clinical study titled "Predicting Analgesic Response to Acupuncture: A Practical Approach". In this placebo controlled, patient and assessor blinded clinical trial, the investigators will administer electroacupuncture vs sham electroacupuncture to patients suffering from chronic low back pain, and monitor their symptoms as well as collecting objective outcome measures. The investigators ob...
What is the current status of trial NCT02890810?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2016-07. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT02890810?
The interventions under investigation include: Real Acupuncture with Electrical Stimulation (OTHER), Simulated Acupuncture with Electrical Stimulation (OTHER).
Who is sponsoring clinical trial NCT02890810?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02890810's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia